BOCA RATON, FL--(Marketwire - November 10, 2008) - Vicor Technologies, Inc. (OTCBB: VCRT) announced that the interview with its Chief Medical Officer, Daniel N. Weiss, M.D., FACC, on “Cutting Edge with Anita” is available on the Company’s website: www.vicortech.com. Vicor is a biotechnology company that has developed the PD2i, a patented, proprietary algorithm and is now awaiting FDA 510 (k) clearance for its first product, the PD2i Analyzer that measures heart rate variability. The Company is also involved in clinical trials for 510(k) clearance for use of the PD2i algorithm in a) risk stratifying combat and civilian trauma victims (PD2i VS) and b) identifying patients at risk of suffering Sudden Cardiac Death (PD2i CA).
